Abstract
Some recent advances in the search for tumor‐specific immunity in man are reviewed. The development of new techniques for the in vitro detection of tumor‐induced immune reactions has led to the discovery of both cell‐mediated and humoral immunity induced by a variety of human tumors. Malignant melanomas, Burkitt's lymphomas, neuroblastomas, and choriocarcinomas rank high on the list of antigenic tumors and are associated with a better than average prognosis. Immunotherapy based on the antigenic differences between normal and tumor cells is briefly discussed. Copyright © 1970 American Cancer Society
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
